Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors
Clinical trial NCT00417807 · COMPLETED
Trial details
- NCT number
- NCT00417807
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2009-06-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.